Table 1. Clinicopathological characteristics of patients affected by rectal cancer of median and distal localization, accordantly to the criteria for the nCRT [21].
| Patient nr. | Sex | Age | Pre-CRT stage TNM | TRG | TRG group of analysis |
|---|---|---|---|---|---|
| 1 | F | 62 | T3N0 | 1 | 1-2 |
| 2 | F | 51 | T3N+ | 2 | |
| 3 | M | 62 | T1/2N0 | 1 | |
| 4 | M | 59 | T3N+ | 1 | |
| 5 | M | 64 | T3N+ | 3 | 3 |
| 6 | M | 66 | T3N0 | 3 | |
| 7 | M | 49 | T3N+ | 3 | |
| 8 | M | 59 | T3N+ | 3 | |
| 9 | M | 68 | T3N0 | 3 | |
| 10 | M | 58 | T3N+ | 3 | |
| 11 | M | 43 | T3N+ | 3 | |
| 12 | F | 64 | T3/4N+ | 4 | 4 |
| 13 | M | 61 | T3N0 | 4 | |
| 14 | M | 83 | T3N0 | 4 | |
| 15 | M | 67 | T3N0 | 4 |
Pathological responses were evaluated with the tumor regression grade (TRG) system.